Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria
FNJ Frakking, WC Rottier… - Antimicrobial agents …, 2013 - Am Soc Microbiol
We studied clinical characteristics, appropriateness of initial antibiotic treatment, and other
factors associated with day 30 mortality in patients with bacteremia caused by extended …
factors associated with day 30 mortality in patients with bacteremia caused by extended …
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
G Peralta, M Lamelo, P Álvarez-García… - BMC infectious …, 2012 - Springer
Background The objective of this study is to analyze the factors that are associated with the
adequacy of empirical antibiotic therapy and its impact in mortality in a large cohort of …
adequacy of empirical antibiotic therapy and its impact in mortality in a large cohort of …
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate …
M Tumbarello, M Sanguinetti, E Montuori… - Antimicrobial agents …, 2007 - Am Soc Microbiol
Bloodstream infections (BSI) caused by extended-spectrum β-lactamase (ESBL)-producing
organisms markedly increase the rates of treatment failure and death. We conducted a …
organisms markedly increase the rates of treatment failure and death. We conducted a …
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli
M Melzer, I Petersen - Journal of Infection, 2007 - Elsevier
OBJECTIVES: To determine the differences in mortality and length of hospital stay in
patients with bacteraemic infection caused by ESBL and non-ESBL producing Escherichia …
patients with bacteraemic infection caused by ESBL and non-ESBL producing Escherichia …
[PDF][PDF] Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL
M Falcone, A Vena, M Mezzatesta, F Gona, C Caio… - Ann Ig, 2014 - researchgate.net
Backgroung: Bloodstream infection (BSI) due to extended-spectrum β-lactamase (ESBL)
producing Enterobacteriaceae are a major cause of in-hospital mortality. The effect on …
producing Enterobacteriaceae are a major cause of in-hospital mortality. The effect on …
Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department
Extended-spectrum β-lactamase (ESBL)-producing bacteria have been spreading from
hospitals to communities. Despite this, there are limited emergency department (ED) patient …
hospitals to communities. Despite this, there are limited emergency department (ED) patient …
National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum β …
D Marchaim, T Gottesman, O Schwartz… - Antimicrobial agents …, 2010 - Am Soc Microbiol
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are pathogens that
may lead to a spectrum of clinical syndromes. We aimed to identify predictors and outcomes …
may lead to a spectrum of clinical syndromes. We aimed to identify predictors and outcomes …
Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing …
CJ Hsieh, YH Shen, KP Hwang - Journal of Microbiology, Immunology and …, 2010 - Elsevier
BACKGROUND/PURPOSE: Infections caused by extended-spectrum β-lactamase (ESBL)-
producing bacteria have become a serious clinical concern worldwide. The occurrence of …
producing bacteria have become a serious clinical concern worldwide. The occurrence of …
Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special …
CI Kang, YM Wi, KS Ko, DR Chung… - … journal of infectious …, 2013 - Taylor & Francis
Background: Although extended-spectrum beta-lactamase (ESBL)-producing Escherichia
coli has emerged as a significant pathogen, there is little information regarding treatment …
coli has emerged as a significant pathogen, there is little information regarding treatment …
Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae
MJ Schwaber, S Navon-Venezia, KS Kaye… - Antimicrobial agents …, 2006 - Am Soc Microbiol
We studied outcomes of extended-spectrum β-lactamase (ESBL) production in
Enterobacteriaceae bacteremia. Inpatients with bacteremia caused by ESBL-producing …
Enterobacteriaceae bacteremia. Inpatients with bacteremia caused by ESBL-producing …